A new report from scientists at Massachusetts General Hospital and colleagues in centers around the world finds that common variants in 28 regions of DNA — 16 previously unsuspected — are associated with blood pressure in human patients. They also identified for the first time the involvement of an important physiologic pathway in blood pressure control, potentially leading to a totally new class of hypertension drugs.